Resseptor Therapeutics is a biotechnology company based in Melbourne, Australia. It is primarily engaged in the discovery and development of small molecule drugs that target G protein-coupled receptors (GPCRs). The company's research is focused on areas with significant unmet medical needs, such as neurology, metabolic diseases, and inflammation.

Founded by a group of experienced scientists and entrepreneurs, Resseptor Therapeutics collaborates with several academic and research institutions to develop its drug candidates. The company is dedicated to advancing its programs into clinical development and ultimately delivering effective treatments to patients. It is steadfast in its commitment to improving human health through the development of novel therapeutics.

Connect